Biological markers of atypical depression
by
Posternak MA.
Department of Psychiatry and Human Behavior,
Brown University School of Medicine,
Providence, RI, USA.
mposternak@lifespan.org
Harv Rev Psychiatry. 2003 Jan-Feb;11(1):1-7


ABSTRACT

The atypical features subtype of major depressive disorder was introduced into DSM-IV largely on the basis of the preferential response shown by a subset of depressed patients to monoamine oxidase inhibitors. In the present report, studies evaluating the biological nature of atypical depression are reviewed to determine whether they support the existence of this subtype. Four lines of research are considered: studies involving hypothalamic-pituitary-adrenal axis activity, cerebral laterality, neurochemical profiles, and sleep parameters. Taken together, the findings of these investigations do support the existence of the atypical features subtype. Furthermore, many of the features known to be associated with atypical depression, such as higher prevalence in women, higher prevalence of comorbid anxiety disorders, and younger age of onset, may be accounted for by the biological underpinnings of the disorder.
TCAs
SSRIs
MAOIs
Options
Recovery
Bupropion
Reboxetine
Nefazodone
Mirtazapine
Venlafaxine
Depressive realism
Atypical depression
Retarded depression
New antidepressants
Depression without sadness
Oversleeping and overeating
Atypical depression: treatment
The atypical subtype of depression
Atypical depression and personality
Atypical depression and noradrenaline
Atypical depression and soft bipolarity


Refs
and further reading

HOME
HedWeb
Nootropics
erythroxylum-coca.com
Future Opioids
BLTC Research
MDMA/Ecstasy
Superhapiness?
Utopian Surgery?
The Abolitionist Project
The Hedonistic Imperative
The Reproductive Revolution
Critique of Huxley's Brave New World

The Good Drug Guide
The Good Drug Guide

The Responsible Parent's Guide
To Healthy Mood Boosters For All The Family